101 related articles for article (PubMed ID: 7509981)
1. Role of endogenous endothelin in extension of rabbit myocardial infarction.
Kusumoto K; Awane Y; Fujiwara S; Watanabe T
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S339-42. PubMed ID: 7509981
[TBL] [Abstract][Full Text] [Related]
2. Endogenous endothelin-1 impairs endothelium-dependent relaxation after myocardial ischemia and reperfusion.
Hagar JM
Am J Physiol; 1994 Nov; 267(5 Pt 2):H1833-41. PubMed ID: 7977813
[TBL] [Abstract][Full Text] [Related]
3. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
McMurdo L; Thiemermann C; Vane JR
Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665
[TBL] [Abstract][Full Text] [Related]
4. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats.
Watanabe T; Suzuki N; Shimamoto N; Fujino M; Imada A
Circ Res; 1991 Aug; 69(2):370-7. PubMed ID: 1860178
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts.
Grover GJ; Sleph PG; Fox M; Trippodo NC
J Pharmacol Exp Ther; 1992 Dec; 263(3):1074-82. PubMed ID: 1469621
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats.
Watanabe T; Awane Y; Ikeda S; Fujiwara S; Kubo K; Kikuchi T; Kusumoto K; Wakimasu M; Fujino M
Br J Pharmacol; 1995 Mar; 114(5):949-54. PubMed ID: 7780649
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1-induced reduction of myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion.
Hide EJ; Piper J; Thiemermann C
Br J Pharmacol; 1995 Nov; 116(6):2597-602. PubMed ID: 8590976
[TBL] [Abstract][Full Text] [Related]
9. Role of Na(+)-H+ exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts.
Khandoudi N; Ho J; Karmazyn M
Circ Res; 1994 Aug; 75(2):369-78. PubMed ID: 8033346
[TBL] [Abstract][Full Text] [Related]
10. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA).
Zhao L; Kirsch CC; Hagen SR; Elliott GT
J Mol Cell Cardiol; 1996 Jan; 28(1):197-208. PubMed ID: 8745227
[TBL] [Abstract][Full Text] [Related]
11. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
Wang QD; Li XS; Lundberg JM; Pernow J
Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284
[TBL] [Abstract][Full Text] [Related]
13. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion.
Kelly RF; Hursey TL; Schaer GL; Piotrowski MJ; Dee SV; Parrillo JE; Hollenberg SM
J Investig Med; 1996 Dec; 44(9):575-82. PubMed ID: 9035612
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044.
Kojima M; Kusumoto K; Fujiwara S; Watanabe T; Fujino M
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S365-8. PubMed ID: 8587416
[TBL] [Abstract][Full Text] [Related]
15. Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.
Miki T; Miura T; Bünger R; Suzuki K; Sakamoto J; Shimamoto K
Am J Physiol; 1998 Oct; 275(4):H1329-37. PubMed ID: 9746483
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart.
Wang P; Gallagher KP; Downey JM; Cohen MV
J Mol Cell Cardiol; 1996 Mar; 28(3):579-88. PubMed ID: 9011641
[TBL] [Abstract][Full Text] [Related]
17. Coronary vasoconstriction mediated by endothelin-1 in neonates. Reversal by nitroglycerin.
McGowan FX; Davis PJ; Siewers RD; del Nido PJ
J Thorac Cardiovasc Surg; 1995 Jan; 109(1):88-97; discussion 97-8. PubMed ID: 7815811
[TBL] [Abstract][Full Text] [Related]
18. Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining.
Birnbaum Y; Hale SL; Kloner RA
J Mol Cell Cardiol; 1997 Feb; 29(2):657-66. PubMed ID: 9140823
[TBL] [Abstract][Full Text] [Related]
19. Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size.
Lee R; Nitta T; Schmid RA; Schuessler RB; Harris KM; Gay WA
Ann Thorac Surg; 1998 May; 65(5):1353-9. PubMed ID: 9594866
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-receptor antagonist FR 139317 reduces infarct size in a rabbit model when given before, but not after, coronary artery occlusion.
Burke SE; Nelson RA
J Cardiovasc Pharmacol; 1997 Jan; 29(1):87-92. PubMed ID: 9007676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
